Abbreviations used in this paper: AA, arachidonic acid; cPLA~2~, cytosolic phospholipase A~2~; fMLP, formyl-methionyl-leucyl-phenylalanine; OZ, opsonized zymosan; PtdIns(4,5)P~2~, phosphatidylinositol 4,5-bisphosphate.

Introduction
============

The NADPH oxidase is a multicomponent electron transport chain that transfers electrons from NADPH to molecular oxygen to form superoxide, a precursor of microbicidal oxidants. The production of superoxide by NADPH oxidase is one of the most important functions for host defense. However, during altered physiological states reactive oxygen products may promote inflammatory reactions and participate in processes that lead to tissue injury. An understanding of the biochemical processes that regulate NADPH oxidase activity may provide a means to more effectively control the activity of the cells during infection and inflammation. In resting neutrophils, NADPH oxidase is dormant, with unassembled subunits located on the cytosol and the plasma membranes ([@bib2]; [@bib34]; [@bib3]). Upon stimulation, the cytosolic components p47^phox^, p67^phox^, p40^phox^, and rac2 translocate to the plasma membranes and associate with the heterodimeric transmembrane glycoprotein, flavocytochrome b~558~. The cytochrome is comprised of two subunits, gp91^phox^ and p22^phox^, that contain heme, flavin, and NADPH-binding sites ([@bib61]; [@bib2]; [@bib34]; [@bib72]; [@bib62]). The two cytosolic components, p47^phox^ and p67^phox^, contain Src homology 3 motifs that direct their translocation to the membranes by binding to specific targets in p22^phox^ and to each other ([@bib34]). p47^phox^ and p40^phox^ subunits contain phox homology domains that specifically bind to phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3-phosphate ([@bib15]; [@bib28]; [@bib58]). These phox homology domains are thought to participate in directing the subunits to the membranes and in assembling the oxidase complex ([@bib54]; [@bib28]; [@bib65]).

Cytosolic phospholipase A~2~ (cPLA~2~) which hydrolyzes phospholipids containing arachidonate at the sn-2 position ([@bib8]; [@bib33]), has been implicated as the major enzyme in the formation of proinflammatory lipid mediators. Recently, we have created in the human phagocyte myeloid cell line, PLB-985, a p85 cPLA~2~-deficient model cell ([@bib11]) and demonstrated an essential requirement for arachidonic acid (AA) in activation of the assembled phagocyte NADPH oxidase, the oxidase-associated H^+^ channel ([@bib40]), and the oxidase-associated diaphorase activity ([@bib52]) induced with a variety of agonists. The normal translocation of the oxidase cytosolic components in activated differentiated PLB-985 cells lacking cPLA~2~ or in stimulated neutrophils in the presence of PLA~2~ inhibitors ([@bib38]; [@bib11]; [@bib52]) and the effect of PLA~2~ inhibitors even when added after oxidase activation ([@bib24]) indicate that cPLA~2~ is not required for translocation of the cytosolic factors to the membranes but rather serves a critical role in oxidase activation after the assembly of the oxidase complex. Addition of free AA but not other free fatty acids nor AA metabolites restored the activity, indicating the specificity of AA for the process. The requirement of cPLA~2~ for oxidase activation is consistent with our and other previous studies in human neutrophils and monocytes ([@bib24]; [@bib10]; [@bib39]; [@bib4]). In addition, a recent study ([@bib73]) has demonstrated by the use of antisense molecules that cPLA~2~ is absolutely required for superoxide generation in monocytes stimulated with opsonized zymosan. However, that study suggests that cPLA~2~ is required for translocation of oxidase cytosolic components to the membranes and not to activation of the assembled oxidase. The discrepancy may be due to the different roles of cPLA~2~ in the different cell types, as proposed by the authors. In contrast to the findings demonstrating requirement of the cPLA~2~ for oxidase activation, resident peritoneal macrophages from cPLA~2~-deficient mice exhibited normal stimulated superoxide release ([@bib19]), which may be attributed to either compensatory effects of isoenzymes frequently observed in models of knockout animals or to the known differences of the PLA~2~ isotypes between mice and human/rat ([@bib68]). In an earlier study, we showed that AA increases the affinity of the assembled oxidase in purified membranes for NADPH ([@bib57]). The mechanism by which cPLA~2~ regulates the NADPH oxidase activity is not known, particularly since the NADPH oxidase complex is localized in the plasma membrane in stimulated cells, whereas cPLA~2~ has been shown to translocate to the nuclear and ER membranes in a variety of cells (for review see [@bib25]). To elucidate the mechanism by which cPLA~2~ regulates the activation of NADPH oxidase, the present study investigated the cellular localization of cPLA~2~ upon stimulation and whether there is any association between cPLA~2~ and the NADPH oxidase complex during activation of phagocytic cells.

Results
=======

Coimmunoprecipitation of cPLA~2~ with NADPH oxidase in membranes of activated neutrophils
-----------------------------------------------------------------------------------------

The association between cPLA~2~ and NADPH oxidase was studied by performing coimmunoprecipitation experiments in resting and stimulated neutrophils with either 1 mg/ml opsonized zymosan (OZ), 50 ng/ml PMA, or 5 × 10^−7^ M formyl-methionyl-leucyl-phenylalanine (fMLP). As shown in [Fig. 1](#fig1){ref-type="fig"}, addition of antibodies against either p47^phox^ or p67^phox^ resulted in significant immunoprecipitation of the cytosolic components in the membrane fractions of the activated neutrophils. cPLA~2~ was coimmunoprecipitated with either of the cytosolic components (p47^phox^ or p67^phox^) in the membrane fractions of activated neutrophils but not in the membranes of resting neutrophils. In spite of the high levels of p47^phox^ or p67^phox^ immunoprecipitated in the cytosol of resting or activated neutrophils, coimmunuprecipitation of cPLA~2~ was not detected. To confirm the binding between cPLA~2~ and the NADPH oxidase complex, cPLA~2~ was immunoprecipitated, and its association with oxidase components was analyzed. As shown in [Fig. 2](#fig2){ref-type="fig"} A, cPLA~2~ was immunoprecipitated in the membrane fractions of neutrophils activated for 1 min with either OZ, fMLP, or PMA. The NADPH oxidase components, p47^phox^, p67^phox^, and gp91^phox^, were coimmunoprecipitated with cPLA~2~ in the membrane fractions of activated cells. Traces of cPLA~2~ and the oxidase components detected in membranes of resting cells ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) are probably due to some basal stimulation of neutrophils during purification. When cPLA~2~ immunoprecipitation was done with preimmune serum, neither cPLA~2~ nor the oxidase components were detected (unpublished data), confirming the specificity of the assay. Pretreatment of neutrophils with 5 μg/ml cytochalasin b, which prevents actin polimerization and disrupts cytoskeleton integrity ([@bib17]; [@bib69]; [@bib63]), did not affect the binding between cPLA~2~ and the assembled oxidase in membranes of the stimulated neutrophils ([Fig. 2](#fig2){ref-type="fig"} B). Although several studies have suggested that the functional oxidase complex at the plasma membranes is associated with the cytoskeleton ([@bib47]; [@bib13]; [@bib1]), the present findings suggest that assembly of the NADPH oxidase complex and its association with cPLA~2~ stimulated by these agonists are independent of an intact cytoskeleton in nonadherent neutrophils. Furthermore, in accordance with these results superoxide generation and translocation of the cytosolic oxidase components to membranes of nonadherent neutrophils pretreated with cytochalasin b was increased when stimulated with fMLP or OZ but was not affected when stimulated with PMA (unpublished data; [@bib13]; [@bib71]; [@bib27]).

![**Coimmunoprecipitation of cPLA** ~2~ **with p67^phox^ or p47^phox^ in membranes of stimulated neutrophils.** Neutrophils were stimulated with 1 mg/ml OZ, 5 × 10^−7^M fMLP, or 50 ng/ml PMA for 1 min at 37°C. The cell cytosol and solubilized membranes were subjected to immunoprecipitation (IP) with anti-p67^phox^ or anti-p47^phox^ antibodies. The immunoprecipitates were separated by SDS-PAGE electrophoresis, and immunoblotting was performed with anti-cPLA~2~ antibodies. The levels of p67^phox^ or p47^phox^ immunoprecipitated were evaluated by immunoblot analysis. The results shown are from one representative experiment out of three that gave identical results.](200211056f1){#fig1}

![**Coimmunoprecipitation of NADPH oxidase components with cPLA** ~2~ **in membranes of activated neutrophils.** Neutrophils (A) and neutrophils (B) preincubated with 5 μg/ml cytochalasin b for 10 min at 37°C were stimulated as in the legend to [Fig. 1](#fig1){ref-type="fig"}. cPLA~2~ immunoprecipitation (IP) was performed in solubilized neutrophil membranes, applied to SDS-PAGE electrophoresis, and followed by immunoblotting with anti-gp91^phox^, anti-p67^phox^, and anti-p47^phox^ antibodies. The levels of cPLA~2~ immunoprecipitated were evaluated by immunoblot analysis. The results shown are from one representative experiment out of three that gave identical results. (C) Immunoblot of cPLA~2~ in neutrophil lysates. Preimmune serum (pre) did not detect any protein, whereas the antibodies raised against cPLA~2~ detected one band in the neutrophil lysates.](200211056f2){#fig2}

Translocation of cPLA~2~ to the plasma membranes of activated neutrophils
-------------------------------------------------------------------------

To determine the exact subcellular localization of cPLA~2~ after neutrophil activation, resting and stimulated cells were fractionated onto a three-step discontinuous Percoll gradient, resulting in the separation of azurophil granules (α), the specific granules (β~1~ and β~2~), and the plasma membranes/secretory vesicles (γ). [Fig. 3](#fig3){ref-type="fig"} demonstrates that both cPLA~2~ and p47^phox^ were associated with the γ fraction of PMA-stimulated neutrophils as shown earlier for p47^phox^ ([@bib14]; [@bib43]). Neutrophil stimulation with either fMLP or OZ produced the same results (unpublished data).

![**Subcellular localization of cPLA~2~ in neutrophils.** 5 × 10^8^ neutrophils, either unperturbed or stimulated with PMA, were disrupted by N~2~ cavitation. The postnuclear supernatant was loaded on a three-layer Percoll gradient. The α, β~1~, β~2~, and γ fractions were formed as described in Materials and methods, separated on SDS-PAGE electrophoresis, and subjected to immunoblot analysis with anti-p47^phox^ and anti-cPLA~2~ antibodies. The results are from one representative experiment out of three that gave identical results.](200211056f3){#fig3}

Time course binding between cPLA~2~ and the assembled NADPH oxidase
-------------------------------------------------------------------

The binding kinetics between cPLA~2~ and the assembled NADPH oxidase were studied in peripheral blood neutrophils and in granulocyte-like PLB-985 cells and revealed identical results, as shown for granulocyte-like PLB-985 cells in [Fig. 4](#fig4){ref-type="fig"}. Immunoprecipitation of cPLA~2~ from solubilized membrane fractions could be detected as early as 30 s after stimulation, reaching maximal levels after 1 min of stimulation with either 1 mg/ml OZ or 5 × 10^−7^ M fMLP and decreasing thereafter ([Fig. 4, A and C](#fig4){ref-type="fig"}). Similar results were obtained when the cells were stimulated with 50 ng/ml PMA, with maximal levels after 3 min of stimulation ([Fig. 4](#fig4){ref-type="fig"} B). Since cPLA~2~ was immunoprecipitated from the membranes, its level dictated the levels of coimmunoprecipitated p47^phox^ and p67^phox^ ([Fig. 4](#fig4){ref-type="fig"}, A--C). Thus, the time course appearance of cPLA~2~, p47^phox^, and p67^phox^ to the membranes after stimulation was analyzed in order to compare translocation kinetics of these proteins. As shown in [Fig. 4, D--F](#fig4){ref-type="fig"}, the oxidase cytosolic components were rapidly and simultaneously translocated to the solubilized membrane fractions after stimulation, preceding the translocation of cPLA~2~. These results are in line with our previous studies ([@bib38]; [@bib11]; [@bib52]), demonstrating that the translocation of the oxidase cytosolic components is independent of cPLA~2~. As shown in [Fig. 4, D--F](#fig4){ref-type="fig"}, the kinetics of cPLA~2~ translocation to the membranes is dependent on the translocation of the kinetics of oxidase cytosolic components and is more rapid when stimulated with OZ or fMLP than with PMA, which is consistent with the development of the burst of superoxides by these agonists ([Fig. 4](#fig4){ref-type="fig"}, G--I). Significant translocation of cPLA~2~ to the membranes of stimulated cells was detected before the production of superoxides, whereas maximal translocation of cPLA~2~ was detected at 1 min of stimulation with OZ or fMLP and at 3 min of stimulation with PMA ([Fig. 4](#fig4){ref-type="fig"}, D--F), which coincided with the onset of superoxide production by these three agonists ([Fig. 4](#fig4){ref-type="fig"}, G--I). The detachment of cPLA~2~ from the membrane fractions precedes that of the cytosolic components p47^phox^ and p67^phox^ ([Fig. 4](#fig4){ref-type="fig"}, D--F) and takes place while NADPH oxidase is still being activated to generate superoxide ([Fig. 4](#fig4){ref-type="fig"}, G--I).

![**The time course association and translocation of cPLA~2~ and the cytosolic components of NADPH oxidase in membranes of stimulated granulocyte-like PLB-985 cells.** PLB-985 cells were differentiated with 1.25% DMSO for 4 d. The cells were stimulated with 1 mg/ml OZ (A), 50 ng/ml PMA (B), or 5 × 10^−7^ M fMLP (C) for the indicated times at 37°C. The cell membranes were subjected to immunoprecipitation (IP) with anti-cPLA~2~ antibodies, followed by immunoblot of p67^phox^ and p47^phox^. The bottom lane in each experiment shows the levels of cPLA~2~ detected in the immunoprecipitates. Time course translocation of cPLA~2~, p67^phox^, and p47^phox^ to cell membranes after stimulation with OZ (D) PMA (E), or fMLP (F) was detected by immunoblot analysis. 2 × 10^6^ cell membrane equivalent were applied per lane. Superoxide production stimulated with either OZ (G), PMA (H), or fMLP (I) as detected by cytochrome C reduction. The results are from one representative experiment out of three presenting identical results.](200211056f4){#fig4}

To determine the molar ratio between the assembled oxidase and cPLA~2~ in the membranes after stimulation, the levels of cPLA~2~ and of p47^phox^ (which are representative of the assembled oxidase) in the same membranes from stimulated neutrophils were analyzed by quantitative Western blotting as done by others ([@bib56]). Representative blots and standard curves obtained by quantitative densitometry of recombinant proteins are shown in [Fig. 5](#fig5){ref-type="fig"}. Quantitative analysis revealed that cPLA~2~ and p47^phox^ translocated to the membranes by the three agonists at a molar ratio of 1:25. Actual measured values for cPLA~2~ derived from the standard curves were 2.1, 1.6, or 2.3 ng/sample, which were calculated as 25, 20, or 28 pmoles/sample in the membranes from neutrophils stimulated with OZ, fMLP, or PMA, respectively. Actual measured values for p47^phox^ derived from the standard curves were 28, 23, or 31 ng/sample, which were calculated as 604, 504, or 673 pmoles/sample in the membranes from cells stimulated with OZ, fMLP, or PMA, respectively. Despite the different levels of p47^phox^ translocated to the membrane induced by the different agonists, the molar ratio between cPLA~2~ and p47^phox^ was similar, indicating that the level of p47^phox^ determines the level of cPLA~2~ that translocates to the membranes. Similar results were obtained in granulocyte-like PLB-985 cells.

![**The molar ratio between cPLA~2~ and NADPH oxidase in the membranes of stimulated cells.** Samples of recombinant cPLA~2~ or p47^phox^ and membranes (bottom inset) of neutrophils stimulated with 1 mg/ml OZ, 5 × 10^−7^ M fMLP for 1 min or 50 ng/ml PMA for 3 min (top inset) were analyzed by SDS-PAGE electrophoresis. 2 × 10^6^ cell membrane equivalents were applied per lane. The Western blots were analyzed using quantitative densitometry, and the relative optical density of each band was plotted against the amount of protein added per lane. The correlation coefficient for the cPLA~2~ standard curve is 0.99 and for the p47^phox^ standard curve is 0.92. The quantities of cPLA~2~ and p47^phox^ in membranes of stimulated cells were determined from the standard curves. The results are from one representative experiment out of three presenting identical results.](200211056f5){#fig5}

In vivo location of cPLA~2~ in resting and activated cells
----------------------------------------------------------

Based on the in vitro binding between cPLA~2~ and NADPH oxidase in plasma membranes of stimulated cells, we examined the in vivo location of cPLA~2~ in resting and activated cells by immunofluorescence microscopy. Granulocyte-like PLB-985 cells are advantageous for the study: first, the expression of gp91^phox^ can be manipulated in these cells ([@bib74]), thus enabeling determination of the role of oxidase for targeting cPLA~2~ to the plasma membranes, and second, PLB-985 cells differentiated with DMSO exhibit different kinetics for superoxide production ([Fig. 4](#fig4){ref-type="fig"}) and for eicosonoid formation (shown at the end of this section), thus facilitating a means to detect the location of cPLA~2~ in different compartments after stimulation. Double staining immunofluorescence analysis of cPLA~2~ and the membrane oxidase component gp91^phox^ showed that cPLA~2~ is found in the cytosol of resting granulocyte-like PLB-985 cells ([Fig. 6](#fig6){ref-type="fig"} A). Upon stimulation with either PMA, OZ, or fMLP, a significant translocation of cPLA~2~ to the cell periphery was detected where it colocalized with gp91^phox^, confirming the localization of cPLA~2~ in the plasma membranes of activated phagocytic cells. No increase in the gp91^phox^ immunofluorescence signal was detected after stimulation with either of the agonists ([Fig. 6](#fig6){ref-type="fig"} A), which is in line with the low levels of granules, including gp91^phox^ endomembranes, present in PLB-985 cells differentiated with DMSO but in contrast to PLB-985 cells differentiated with 1,25(OH)~2~D~3~ (unpublished data) or to PLB-985 cells differentiated with DMF ([@bib50]). The kinetics of cPLA~2~ translocation stimulated with fMLP is depicted in [Fig. 6](#fig6){ref-type="fig"} B. Maximal levels of cPLA~2~ were detected in the cell periphery 1 min after stimulation. 5 min after stimulation, a significant fraction of cPLA~2~ reappeared in the cytosol. This subcellular localization of cPLA~2~ stimulated with fMLP is similar to that detected by immunoblotting analysis ([Fig. 4](#fig4){ref-type="fig"} D). The immediate translocation of cPLA~2~ to the membranes correlates with the rapid onset of superoxide upon stimulation ([Fig. 4](#fig4){ref-type="fig"}). Translocation of cPLA~2~ to the nucleus was studied by double labeling of cPLA~2~ and of lamin B as a marker for nuclear membranes ([@bib49]). As shown in [Fig. 6](#fig6){ref-type="fig"} C, activation of the cells with fMLP for 15 min induced translocation of cPLA~2~ to the nuclear membranes where it colocalized with lamin B. To determine the kinetics of cPLA~2~ translocation to the nuclear membranes, the nuclei of cells stimulated for different time duration were separated and analyzed for the presence of cPLA~2~ by immunoblot analyses. Translocation of cPLA~2~ to the nuclear membranes could be detected only 15 min after stimulation, in correlation with the time course of PGE~2~ secretion as shown in [Fig. 6](#fig6){ref-type="fig"} D, which depicts stimulation of granulocyte-like PLB cells with fMLP. Similar results were obtained with PMA and OZ (unpublished data).

![**Subcellular localization of cPLA~2~ in stimulated granulocyte-like PLB-985 cells.** (A) Granulocyte-like PLB-985 cells before and after stimulation with 1 mg/ml OZ, 5 × 10^−7^ M fMLP for 1 min or 50 ng/ml PMA for 3 min at 37°C were fixed, permeabilized, and incubated with anti-cPLA~2~ and anti-gp91^phox^ antibodies and then with cy3- and cy2-conjugated second antibodies, respectively. cPLA~2~ was found in the cytosol in resting cells and colocalized with gp91^phox^ in the plasma membranes in stimulated cells. An engulfed OZ particle (stained in red as indicated by the white arrow) is surrounded by plasma membranes in which gp91^phox^ and cPLA~2~ colocalized (×1,000). (B) The time course translocation of cPLA~2~ to cell periphery after stimulation with 5 × 10^−7^ M fMLP (×400). (C) Lamin B was labeled by anti--lamin B antibodies and then with cy2-conjugated second antibodies. cPLA~2~ colocalized with lamin B in nuclear membranes of stimulated cells with 5 × 10^−7^ M fMLP for 15 min (×1,000). (D) The kinetics ± SEM of PGE~2~ production (of three experiments, each in triplicates) and of cPLA~2~ translocation to the nuclear fractions (a representative immunoblot analysis of the three experiments) in 5 × 10^6^ cells/ml granulocyte-like PLB-985 cells after stimulation with 5 × 10^−7^ M fMLP. 2 × 10^6^ cell equivalent of nuclear fraction was applied in each lane. Equal amounts of the nuclear fractions were confirmed by detection of the levels of lamin B in each sample by immunoblot analysis.](200211056f6){#fig6}

The role of NADPH oxidase in targeting cPLA~2~ to the plasma membranes
----------------------------------------------------------------------

To determine the role of NADPH oxidase in directing cPLA~2~ to the plasma membranes, we studied the subcellular location of cPLA~2~ in granulocyte-like gp91^phox^-deficient PLB-985 cells in which no oxidase assembly occurs ([@bib5]). As shown by immunoblot analysis, cPLA~2~ could not be detected in membranes of granulocyte-like gp91^phox^-deficient PLB-985 cells stimulated for 1 min with OZ, PMA, or fMLP, whereas it was clearly detected in membrane fractions of stimulated granulocyte-like PLB-985 cells ([Fig. 7](#fig7){ref-type="fig"} A). These results were confirmed by confocal laser scanning microscopy, demonstrating that granulocyte-like gp91^phox^-deficient PLB-985 cells indeed do not express any gp91^phox^ ([Fig. 7](#fig7){ref-type="fig"} B) and that their stimulation with either of the three agonists does not induce any translocation of cPLA~2~ to the cell periphery ([Fig. 7](#fig7){ref-type="fig"} C). However, after expression of retroviral gp91^phox^ protein in these cells, cPLA~2~ translocation to the cell periphery was fully restored ([Fig. 7](#fig7){ref-type="fig"} C), thereby establishing the role of a functional oxidase for targeting cPLA~2~ to the plasma membranes.

![**Absence of gp91^phox^ in the cell membrane prevents cPLA~2~ translocation to the plasma membranes.** (A) Granulocyte-like PLB-985 and granulocyte-like gp91^phox^-deficient PLB-985 cells were stimulated as in the legend to [Fig. 1](#fig1){ref-type="fig"}. The cell membranes were separated on 10% SDS-PAGE and subjected to Western blot analysis against cPLA~2~. The results are from one representative experiment out of three that gave identical results. (B) Resting granulocyte-like and granulocyte-like gp91^phox^-deficient PLB-985 cells were double stained as in the legend to [Fig. 6](#fig6){ref-type="fig"} A. cPLA~2~ is found in the cytosol of both type of cells, whereas gp91^phox^ was detected only in granulocyte-like PLB-985 cells. (C) Granulocyte-like gp91^phox^-deficient PLB-985 cells and the cell line expressing retroviral gp91^phox^ differentiated toward the granulocytic lineage before and after stimulation (as in the legend to [Fig. 1](#fig1){ref-type="fig"}) were double stained (as in the legend to [Fig. 6](#fig6){ref-type="fig"} A). cPLA~2~ is found in the cytosol before and after activation in gp91^phox^-deficient PLB-985 cells but translocates to cell periphery after stimulation following the expression of retroviral gp91^phox^ protein in these cells.](200211056f7){#fig7}

In vitro interaction between cytosolic oxidase components and cPLA~2~
---------------------------------------------------------------------

To determine affinity binding between cPLA~2~ and the oxidase components, GST-p47^phox^ and GST-p67^phox^ fusion proteins were used. As shown in [Fig. 8](#fig8){ref-type="fig"}, cPLA~2~ was pulled down from lysates of stimulated, but not resting, neutrophils by either GST-p47^phox^ or GST-p67^phox^ fusion protein but not from lysates of resting cells, suggesting that the binding occurs only with the phosphorylated form of cPLA~2~. In addition, p67^phox^ was also pulled down by GST-p47^phox^ fusion protein, and p47^phox^ was pulled down by GST-p67^phox^ fusion protein. These experiments demonstrate the in vitro affinity binding between cPLA~2~ and the oxidase cytosolic components but do not determine whether cPLA~2~ is associated independently with both p47^phox^ and p67^phox^ or whether it is bound to one cytosolic component and takes up the other, since p47^phox^ and p67^phox^ are found in a complex at the membranes of activated cells. Similar results were obtained in granulocyte-like PLB-985 cells (unpublished data). Although cPLA~2~ was specifically bound to each of the oxidase cytosolic components in vitro using recombinant GST fusion proteins, such binding between cPLA~2~ and the soluble p47^phox^ and p67^phox^ in the cytosol did not occur in physiological conditions ([Fig. 1](#fig1){ref-type="fig"}). Rather cPLA~2~ binds the cytosolic oxidase components when found in the assembled NADPH oxidase after translocation to the plasma membranes, in accordance with our previous study demonstrating that the assembly of the oxidase is independent of cPLA~2~ ([@bib11]). The behavior of the recombinant GST-fused cytosolic proteins may reflect the effects of the fusion on the conformation and exposure of sites interacting with cPLA~2~ that become exposed in the native proteins only when forming membrane complexes after cell stimulation.

![**Binding between cPLA~2~ and cytosolic oxidase components.** Affinity-binding assay using GST-p67^phox^ or GST-p47^phox^ was performed as described in Materials and methods. GST-p67^phox^ binds p47^phox^ in lysates of resting and stimulated neutrophils (with 50 ng/ml PMA) and binds cPLA~2~ only in lysates of stimulated cells, whereas GST alone was not effective. Similarly, GST-p47^phox^ binds p67^phox^ in lysates of resting and stimulated cells and binds cPLA~2~ only in lysates of stimulated cells.](200211056f8){#fig8}

Discussion
==========

The results of the present study are the first to demonstrate that in granulocytic cells, which contain abundant levels of NADPH oxidase, stimulation induces an immediate and transient recruitment of cPLA~2~ to the plasma membranes, in addition to its already known translocation to the nuclear membranes ([@bib41]). The translocation of cPLA~2~ to the membrane fractions of stimulated neutrophils has been shown earlier by us and by others ([@bib12]; [@bib21]; [@bib41]). In addition, several studies performed in a variety of cells including platelets, fibroblasts, and keratinocytes ([@bib29]; [@bib59]; [@bib44]; [@bib31]) have reported translocation of cPLA~2~ to membrane fractions. However, the present study demonstrates that cPLA~2~ is localized in the plasma membranes upon stimulation. The absence of cPLA~2~ translocation to the plasma membranes in granulocyte-like gp91^phox^-deficient PLB-985 cells and the restoration of cPLA~2~ translocation, after the expression of retroviral gp91^phox^ protein, indicate that NADPH oxidase is responsible for anchoring cPLA~2~ to the plasma membranes. The translocation of cPLA~2~ to the membranes occurred after assembly of the oxidase and coincided with the onset of superoxide production ([Fig. 4](#fig4){ref-type="fig"}). The affinity binding between GST-p47^phox^ or GST-p67^phox^ with cPLA~2~ only in lysates of stimulated cells ([Fig. 8](#fig8){ref-type="fig"}) suggests a direct binding with cPLA~2~ in its phosphorylated form. In earlier studies ([@bib11]), we have shown that AA by itself and not its metabolites is required for activation of the assembled NADPH oxidase enzyme. The colocalization of both enzymes (the assembled NADPH oxidase and cPLA~2~) in the same compartment and their direct binding during the onset of superoxide production provides a means by which AA released by cPLA~2~ is able to activate the assembled NADPH oxidase. The precise mechanism by which AA regulates the NADPH oxidase in whole cells is not yet known. Several studies suggest that AA induces structural changes in NADPH oxidase components that may promote productive interaction between the different oxidase subunits, thereby enabling full oxidase activation or directly affecting the function of flavocytochrome b ([@bib16]). The 1:25 molar ratio between cPLA~2~ to the assembled oxidase in the membranes of stimulated cells ([Fig. 5](#fig5){ref-type="fig"}) indicates that one copy of cPLA~2~ is able to provide sufficient levels of AA for several copies of the NADPH oxidase found in its environment. Our current observations are most consistent with a model in which cPLA~2~-generated AA might be a cofactor acting in the intact phagocytic cell to enhance the affinity of the assembled NADPH oxidase for NADPH ([@bib57]) probably by induction of structural changes. cPLA~2~ dissociates from the membranes before the oxidase cytosolic components ([Fig. 4](#fig4){ref-type="fig"}, D--F) and while the oxidase is still functioning ([Fig. 4](#fig4){ref-type="fig"}, G--I), suggesting that cPLA~2~ is required for the activation of NADPH oxidase but not for maintaining its activity.

Recent studies have suggested that cPLA~2~ has three functionally distinct domains: an NH~2~-terminal C2 domain necessary for Ca^2+^-dependent phospholipid binding, a COOH-terminal Ca^2+^-independent catalytic region ([@bib46]), and a putative pleckstrin homology domain within this region that is responsible for the interaction with phosphatidylinositol 4,5-bisphosphate (PtdIns\[4,5\]P~2~; [@bib45]). Subcellular localization of the various C2 domains upon cytoplasmic \[Ca^2+^\] elevation has been shown to correlate with their phospholipid binding specificity. It has also been shown that the cPLA~2~-C2 domain has specificity to the phosphatidylcholine-rich nuclear envelope and ER ([@bib18]; [@bib51]; [@bib26]) and that aromatic and hydrophobic residues in the calcium binding loop of the cPLA~2~-C2 domain are important for its lipid specificity ([@bib66]). In contrast, the PKCα-C2 domain has specificity to the phosphatidylserine-rich plasma membranes ([@bib48]; [@bib9]) and ASn^189^ plays a key role in this specificity ([@bib66]). Several studies have shown that cPLA~2~ translocates from the cytosol to the nuclear membrane and to the ER by calcium ionophores or agonists such as histamine or IgE/antigen, which increase cytoplasmic \[Ca^2+^\] in a variety of cells ([@bib53]; [@bib20]; [@bib60]; [@bib64]). However, PMA, which does not induce an increase in cytoplasmic \[Ca^2+^\], caused activation and translocation of cPLA~2~ ([@bib21]; [@bib55]), suggesting the existence of alternative pathways that induce translocation of cPLA~2~ not involving elevation of cytoplasmic \[Ca^2+^\], which is necessary for the C2 domain phospholipid binding. The results of our present study suggest that the cPLA~2~-C2 domain does not participate in the translocation of cPLA~2~ to the plasma membranes, since cPLA~2~ translocation is inconsistent with its C2 domain phospholipid binding specificity. In addition, cPLA~2~ translocation to the cell periphery did not occur in the absence of a functional NADPH oxidase ([Fig. 7](#fig7){ref-type="fig"}), and it can be induced with PMA ([Fig. 3](#fig3){ref-type="fig"} and [Fig. 6](#fig6){ref-type="fig"} A), which does not cause elevation of cytoplasmic \[Ca^2+^\]. However, we cannot rule out the possibility that the binding of cPLA~2~ to the assembled oxidase is mediated through the cPLA~2~-C2 domain. Similar to our observation that the C2 domain--containing cPLA~2~ binds NADPH oxidase, a recent study ([@bib43]) has shown that C2 domain--containing protein JFC1, which is restricted to the plasma membranes/secretory vesicles, binds p67^phox^ without affecting the interaction between p47^phox^ and p67^phox^. High levels of PtdIns(4,5)P~2~ have been detected in neutrophil plasma membranes upon stimulation ([@bib7]; [@bib42]), and PtdIns(4,5)P~2~ has been shown to display a particularly dramatic effect on the activity of cPLA~2~ ([@bib45]). However, it seems that the cPLA~2~ pleckstrin homology domain by itself does not play a critical role in targeting cPLA~2~ to the plasma membranes, since in the absence of the functional oxidase cPLA~2~ did not translocate to this compartment, as shown in gp91^phox^-deficient granulocytic PLB-985 cells ([Fig. 7](#fig7){ref-type="fig"}). Thus, the assembled NADPH oxidase appears to be the major determinant in directing cPLA~2~ to the plasma membranes, although the interaction sites among cPLA~2~, NADPH oxidase, and the plasma membranes are not yet defined.

Eicosanoid generation has been shown to be regulated in part by perinuclear envelope localization or translocation of individual enzymes of leukotriene and prostaglandin biosynthesis ([@bib70]). The perinuclear translocation of cPLA~2~, shown in a variety of cells, is in agreement with its role in leukotriene and prostaglandin formation. Similarly, our present study demonstrates a correlation between the kinetics of cPLA~2~ translocation to nuclear membranes and PGE~2~ production in stimulated granulocyte-like PLB-985 cells ([Fig. 6, C and D](#fig6){ref-type="fig"}). The differences in the kinetics of superoxide production and PGE~2~ formation in PLB-985 cells differentiated with DMSO enabled us to efficiently follow the distribution of cPLA~2~ during stimulation, from early translocation to the cell periphery to later translocation to the nuclear envelope. Thus, the mechanism which permits the participation of cPLA~2~ in two different processes in the same cell (regulation of NADPH oxidase and eicosanoid production) is controlled by localization of the enzyme in different subcellular compartments.

In conclusion, the use of combined biochemical and microscopical approaches enhanced our ability to gain better insight into cellular processes and to clearly demonstrate that upon activation of peripheral blood neutrophils and granulocyte-like PLB-985 cells, both of which contain abundant levels of NADPH oxidase, cPLA~2~ translocates to the plasma membranes where it binds the assembled oxidase complex and releases AA, which promotes oxidase activity. The absence of cPLA~2~ in the cell periphery of stimulated granulocyte-like gp91^phox^-deficient PLB-985 cells and its translocation after the expression of retroviral gp91^phox^ protein in these cells indicate that cPLA~2~ is anchored to the plasma membranes by the assembled oxidase. The physical association between these two enzymes enables the regulation of NADPH oxidase by cPLA~2~-generating AA. The novel dual subcellular localization of cPLA~2~ in different compartments, first in the plasma membranes and then in the nucleus, provides a molecular mechanism for the participation of cPLA~2~ in different processes in the same cells. The exact binding sites between these two enzymes and the target for AA action are currently under investigation.

Materials and methods
=====================

Neutrophil purification
-----------------------

Neutrophils were separated by Ficoll/Hypaque centrifugation, dextran sedimentation, and hypotonic lysis of erythrocytes ([@bib11]).

Cell culture and differentiation
--------------------------------

PLB-985 and gp91^phox^-deficient PLB-985 cells lacking the expression of normal gp91^phox^ (provided by M.C. Dinauer, James Whitcomb Riley Hospital for Children, Indianapolis, IN) were grown in stationary suspension culture in RPMI-1640 as described earlier ([@bib11]). The optimal concentration of 1.25% of DMSO was added to 2 × 10^5^ PLB-985 cells/ml at their logarithm growth phase to induce differentiation toward the granulocyte phenotype. Mac-1 antigen determination was detected by indirect immunofluorescence as described previously ([@bib23]).

Isolation of membrane and cytosol fractions
-------------------------------------------

Neutrophils were suspended at 10^7^ cells/ml in phosphate buffer saline and treated with 5 mM diisopropylfluorophosphate for 30 min at room temperature before stimulation. Membrane and cytosol fractions were prepared as described previously ([@bib37]).

Immunoprecipitation
-------------------

Goat antiserum raised against recombinant p47^phox^ or p67^phox^ ([@bib35]) or rabbit antiserum raised against cPLA~2~ ([@bib21]) was added to 3 × 10^7^ membranes or cytosol cell equivalents in 500 μl solubilization buffer (150 mM NaCl, 5 mM EDTA, 10 mM Tris, pH 7.5, 1% sodium deoxycholate, and 1% NP-40), and they were incubated on ice overnight. The extracts were brought to a volume of 1 ml in solubilization buffer containing 30 μl of 50% slurry of recombinant protein G--sepharose. The samples were tumbled end-over-end for 1 h and washed twice with 1 ml solubilization buffer containing 20% (wt/vol) sucrose and 0.15% (wt/vol) BSA and twice with 1 ml solubilization buffer containing 20% sucrose. The samples were boiled in SDS sample buffer and electrophoresed on a 10 or 7% SDS-PAGE. For detection of protein translocation, cell membranes (2 × 10^6^ cell equivalent) were separated by SDS-PAGE electrophoresis. The resolved proteins were electrophoretically transferred to nitrocellulose, and the detection of cPLA~2~ or the oxidase components was analyzed as described previously ([@bib21]).

Subcellular fractionation
-------------------------

Subcellular fractionation was performed as described by others ([@bib32]). Neutrophils (5 × 10^8^) treated with diisopropylfluorophosphate were suspended in relaxation buffer (as described earlier; [@bib37]) and disrupted by nitrogen cavitation at 400 pounds per square inch. Nuclei and unbroken cells were pelleted by centrifugation at 500 *g* for 10 min at 4°C. The supernatant was decanted and loaded onto a precooled discontinuous density gradient Percoll, and 10× concentrated relaxation buffer and distilled water were mixed to give solutions of densities of 1.05, 1.09, and 1.12 g/ml. The gradients were centrifuged at 32,800 *g* for 35 min at 4°C using a fixed angle Beckman Coulter JA20 rotor. Four visible bands were collected, and the markers for azurophil granules (α), specific granules (β), and plasma membranes (γ) were analyzed as described previously ([@bib30]).

Immunofluorescence microscopy
-----------------------------

Preparation of labeled cells was done as described by others ([@bib6]) with some modification. Cells were adhered on coverslips for 30 min at 37°C. The cells were stimulated with various agonists for the desired duration and fixed with 3% (wt/vol) formaldehyde. The first antibodies against cPLA~2~, gp91^phox^, and lamin B (Santa Cruz Biotechnoloy) dissolved in PBS containing 0.2% saponin were added for 1 h at room temperature. cy2- or cy3-conjugated antibodies (Jackson ImmunoResearch Laboratories) were used as secondary antibodies. The fluorescence was visualized using a four channel Zeiss LSM 510 laser scanning confocal microscope (Carl Zeiss MicroImaging, Inc.). The LSM 510 software was used for imaging cPLA~2~, gp91^phox^, and lamin B localization.

Retroviral transduction of gp91^phox^-deficient PLB-985 cells
-------------------------------------------------------------

Retroviaral gp91^phox^ was expressed in gp91^phox^-deficient PLB-985 cells ([@bib74]) as done in our previous study ([@bib52]).

Affinity-binding assay
----------------------

The GST fusion proteins were affinity purified on glutathione-sepharose as described previously ([@bib36]). 50 μl (1 μg) of GST-p47^phox^ or GST-p67^phox^ bound to glutathione-sepharose beads was added to lysates of 5 × 10^7^ resting or stimulated neutrophils prepared as described before ([@bib22]) and was tumbled end-over-end for 2 h at 4°C. Bound proteins were washed three times in 15 vol of ice cold 100 mM KCl, 3 mM NaCl, 3.5 mM MgCl~2~, 0.15 mM PMSF, and 10 mM Pipes (pH 7.5), eluted with 2% SDS, and analyzed by SDS-PAGE followed by immunoblotting with the appropriate antibodies.

Superoxide anion measurements
-----------------------------

The production of superoxide anion (O~2~ ^−^) by intact cells was measured as the superoxide dismutase inhibitable reduction of ferricytochrome c ([@bib11]).

Preparation of nuclei
---------------------

Nuclei were separated from granulocyte-like PLB cells (2 × 10^7^ cells) before and after stimulation as described by others in neutrophils ([@bib67]). Stimulated cells were pelleted and resuspended in 600 μl of ice-cold NP-40 lysis buffer (0.1% NP-40, 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl~2~, 1 mM EDTA, 10 μg/ml leupeptin, 10 μg/ml aprotonin, and 1 mM PMSF). The cells were vortexed for 15 s, kept on ice for 5 min, and centrifuged at 300 *g* for 10 min at 4°C. The resulting pellets (the nuclei containing fractions) were then immediately solubilized in electrophoresis sample buffer and processed for SDS-PAGE and immunoblot determination of cPLA~2~ and the nuclear lamin B. Nuclear integrity was verified directly by light microscopy, which also revealed that intact cells were rarely observed in nuclei-containing fraction (\<2%).

PGE~2~ determination
--------------------

PGE~2~ levels were determined in the supernatant of stimulated cells by RIA using commercial kits (NEN Life Science Products). The samples were immediately stored at −70°C and analyzed during 1 wk of the experiments.
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